期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

慢性阻塞性肺疾病急性加重患者血清CRP、TNF-α和PLA2水平变化及意义 被引量：7

The levels of CRP,TNF-α and PLA2 in patients with acute exacerbation of chronic obstructive pulmonary disease
原文传递
导出
摘要 慢性阻塞性肺疾病急性加重（acute exacerbation ofchronic obstructive pulmonary disease,AECOPD）是COPD患者死亡的重要因素,也是患者医疗费用居高不下的主要原因.AECOPD对患者的生活质量、肺功能、疾病进程和社会经济负担产生严重的负面影响.AECOPD主要特征是持续存在的气流受限,急性加重及合并症影响患者整体疾病的严重程度.
作者 张杰根 戴富林 武凡 刘毅 张占强 张钗
机构地区 河北省涿州市医院呼吸科
出处 《中华肺部疾病杂志（电子版）》 CAS 2014年第3期72-73,共2页 Chinese Journal of Lung Diseases(Electronic Edition)
基金 河北省科技厅科技支撑计划项目课题(11276103D-6)
关键词 肺疾病 慢性阻塞性 急性加重 C反应蛋白 肿瘤坏死因子Α 磷脂酶A2
分类号 R563 [医药卫生—呼吸系统]
  • 相关文献

参考文献10

  • 1无,蔡柏蔷,白春学.慢性阻塞性肺疾病急性加重（AECOPD）诊治中国专家共识（草案）[J].国际呼吸杂志,2012,32(22):1681-1691. 被引量：159
  • 2柳涛,蔡柏蔷.慢性阻塞性肺疾病诊断、处理和预防全球策略(2011年修订版)介绍[J].中国呼吸与危重监护杂志,2012,11(1):1-12. 被引量：728
  • 3中华医学会吸呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊疗指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30:8-17.
  • 4Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease[ J ]. Circulation, 2003, 107 ( 11 ) : 1514-1519.
  • 5Hurst JR, Perera WR, Wilkinson TM, et al. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease [J]. Am J Respir Crit Care Med, 2006, 173 (1): 71-78.
  • 6余苏云,刘翱.TNF-α与COPD关系的研究进展[J].临床肺科杂志,2009,14(12):1655-1656. 被引量：5
  • 7Warwick G, Thomas PS, Yates DH. Non-invasive biomarkers in exacerbations of obstructive lung disease. Respirology, 2013, 18 (5) : 874-884.
  • 8Mangner N, Linke A, Oberbach A, et al. Exercise training prevents TNF-α induced loss of force in the diaphragm of mice. PLoS One, 2013, 8(1) : e52274.
  • 9张炜炜,梁宁生.白细胞和磷脂酶A2关系的研究进展[J].国际免疫学杂志,2008,31(5):356-360. 被引量：2
  • 10Granata F, Nardicchi V, Loffredo S, et al. Secreted phospholipases A (2) : A proinflammatory connection between macrophages and mast cells in the human lung [ J ]. Immunobiology, 2009, 214 (9-10) : 811-821.

二级参考文献38

  • 1俞森洋.慢性阻塞性肺病和哮喘的雾化吸入疗法[J].中国药物应用与监测,2006,3(4):28-31. 被引量：11
  • 2杨银治,夏时海.磷脂酶A_2在炎症反应中的作用[J].世界华人消化杂志,2006,14(8):795-799. 被引量：17
  • 3Gambero A,Thomazzi SM, Cintra AC, et al. Signalling pathways regulating human neutropil migration induced by secretory phospholipases A2. Toxicon ,2004,44 (5) : 473-481.
  • 4Jo EJ,Lee HY, Lee YN, et al. Group IB secretory phospholipase A2 stimulates CXC chemokine ligand 8 production via ERK and NF-kappaB in human neutropils. J Immunol, 2004, 173 (10) : 6433 -6439.
  • 5Triggiani M, Granata F, Balestrieri B, et al. Secretory phospholipases A2 activate selective functions in human eosinophils. J Immunol,2003,170 ( 6 ) : 3279- 3288.
  • 6Christopher CS, Ernest EM, Zallen G, et al. Presence of the M- type sPLA2 receptor on neutrophils and its role in elastase release and adhesion. AJP-Cell Physiol,2002 ,283 ( 4 ) : 1102-1113.
  • 7Jon KF, William MN, Jerrold PW. Synergy between extracellular group Ⅱ A phospholipase A2 and phagocyte NADPH oxidase in digestion of phospholipids of Staphylococcus aureus ingested by human neutrophils. J Immunol,2005,175 (7) : 4653- 4661.
  • 8Hunt CL, Nauseef WM, Weiss JP. Effect of D-alanylation of (lipo) teichoic acids of Staphylococcus aureus on host secretory phospholipase A2 action before and after phagocytosis by human neutrophils. J Immunol,2006,176 (8) :4987-4994.
  • 9Costa-Junior HM, Hamaty FC, da Silva Farlas R, et al. Apoptosis-inducing factor of a cytotoxic T cell line: involvement of a secretory phospholipase A2. Cell Tissue Res, 2006,324 ( 2 ) : 255- 266.
  • 10Tessier C, Hichami A, Khan NA. Implication of three isoforms of PLA(2) in human T-cell proliferation. FEBS Lett,2002,520( 1- 3) :111-116.

共引文献878

同被引文献100

  • 1慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中国医学前沿杂志（电子版）,2014,6(2):67-80. 被引量：2127
  • 2Vestbo J, Hurd SS, Agusti AG, et aI. Global strategy for the di agnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary[J]. Am J Re- spirCrit Care Med, 2013, 187(4) :347 365.
  • 3Azab B,Jaglall N, Atallah JP, et al. Neutrophil lymphocyte ratio as a predictor o{ adverse outcomes o{ acute pancreatitis[J]. Pan ereatology, 2011, 11(4) : 445-452.
  • 4Chang CL,Sullivan GD,Karalus NC,et al. Predicting early mor tality in acute exacerbation of chronic obstructive pulmonary dis ease using the CURB65 score[J]. Respirology, 2011, 16(1) 146-151.
  • 5Roberts CM, Barnes S, Lowe D, et al. Evidence for a link be- tween mortality in acute COPD and hospital type and resources [J]. Thorax, 2008, 58: 947-949.
  • 6Warwick G, Thomas PS, Yates DH. Non-invasive biomarkers in exacerbations of obstructive lung disease[J]. Respirology, 2013,18(5) 874-884.
  • 7Guasti L, Dentali F, Castiglioni L, et al. Neutrophils and clinical outcomes in patients with acute coronary syndromes and/orcardiac revascularisation [J]. Thromb Haemost, 2011, 106 (4) :591-599.
  • 8Akpek M, Kaya MG, Lain YY, et al. Relation of neutrophil/ lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarc- tion undergoing primary coronary intervention[J]. Am J Cardi- ol, 2012,110(5) :621-627.
  • 9Jager CP,Wever PC,Gemen EF,et al. The The neutrophil-lym- phocyte count ratio in patients with community-acquired pneu- monia[J]. PLoS One, 2012, 7(10) : 465-471.
  • 10VESTBO J, HURD SS, AGUSTI AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD excutive summary [J]. Am J Respir. Crit Care Med, 2013,187(4) : 347-365.

引证文献7

二级引证文献133

中华肺部疾病杂志（电子版）
2014年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部